Works matching IS 03065251 AND DT 1983 AND VI 16 AND IP S2
1
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 415S, doi. 10.1111/j.1365-2125.1983.tb02320.x
- Article
2
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 285S, doi. 10.1111/j.1365-2125.1983.tb02302.x
- Jochemsen, R;
- Wesselman, JG;
- Hermans, J;
- Boxtel, CJ;
- Breimer, DD
- Article
3
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 377S, doi. 10.1111/j.1365-2125.1983.tb02313.x
- Mamelak, M;
- Csima, A;
- Price, V
- Article
4
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 433S, doi. 10.1111/j.1365-2125.1983.tb02324.x
- Article
5
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 315S, doi. 10.1111/j.1365-2125.1983.tb02306.x
- Jochemsen, R;
- Joeres, RP;
- Wesselman, JG;
- Richter, E;
- Breimer, DD
- Article
6
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 403S, doi. 10.1111/j.1365-2125.1983.tb02317.x
- Lohmann, H;
- Delbruck, O;
- Findeisen, P
- Article
7
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 205S, doi. 10.1111/j.1365-2125.1983.tb02294.x
- Article
8
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 261S, doi. 10.1111/j.1365-2125.1983.tb02298.x
- Article
9
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 279S, doi. 10.1111/j.1365-2125.1983.tb02301.x
- Article
10
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 371S, doi. 10.1111/j.1365-2125.1983.tb02312.x
- Roehrs, T;
- Zorick, F;
- Koshorek, GL;
- Wittig, R;
- Roth, T
- Article
11
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 425S, doi. 10.1111/j.1365-2125.1983.tb02323.x
- Article
12
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 365S, doi. 10.1111/j.1365-2125.1983.tb02311.x
- Article
13
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 419S, doi. 10.1111/j.1365-2125.1983.tb02322.x
- Ahmad, F;
- Rittmeyer, P;
- Goetzke, E;
- Koster, J
- Article
14
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 309S, doi. 10.1111/j.1365-2125.1983.tb02305.x
- Evers, J;
- Renner, E;
- Bechtel, WD
- Article
15
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 253S, doi. 10.1111/j.1365-2125.1983.tb02297.x
- Kuhn, FJ;
- Boke-Kuhn, K;
- Danneberg, P;
- Lehr, E;
- Stockhaus, K
- Article
16
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 277S, doi. 10.1111/j.1365-2125.1983.tb02300.x
- Article
17
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 347S, doi. 10.1111/j.1365-2125.1983.tb02309.x
- Krueger, H;
- Muller-Limmroth, W
- Article
18
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 397S, doi. 10.1111/j.1365-2125.1983.tb02316.x
- Goetzke, E;
- Findeisen, P;
- Welbers, IB
- Article
19
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 299S, doi. 10.1111/j.1365-2125.1983.tb02304.x
- Jochemsen, R;
- Nandi, KL;
- Corless, D;
- Wesselman, JG;
- Breimer, DD
- Article
20
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 391S, doi. 10.1111/j.1365-2125.1983.tb02315.x
- Delbruck, O;
- Nagel, C;
- Lichterfeld, A
- Article
21
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 333S, doi. 10.1111/j.1365-2125.1983.tb02308.x
- Saletu, B;
- Grunberger, J;
- Linzmayer, L
- Article
22
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 413S, doi. 10.1111/j.1365-2125.1983.tb02319.x
- Fritz-Osner, A;
- Arias-Ortiz, JL;
- Dorantes, JF;
- Rabago-Sanchez, J;
- Rodriguez- Tenorio, A;
- Sanchez-Martinez, J
- Article
23
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 245S, doi. 10.1111/j.1365-2125.1983.tb02296.x
- Article
24
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 355S, doi. 10.1111/j.1365-2125.1983.tb02310.x
- Hartse, KM;
- Thornby, JI;
- Karacan, I;
- Williams, RL
- Article
25
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 417S, doi. 10.1111/j.1365-2125.1983.tb02321.x
- Uzzan, B;
- Warot, D;
- Chermat, P;
- Dantlo, B;
- Bornstein, S;
- Simon, P
- Article
26
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 291S, doi. 10.1111/j.1365-2125.1983.tb02303.x
- Jochemsen, R;
- Wesselman, JG;
- Boxtel, CJ;
- Hermans, J;
- Breimer, DD
- Article
27
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 385S, doi. 10.1111/j.1365-2125.1983.tb02314.x
- Delbruck, O;
- Goetzke, E;
- Nagel, C
- Article
28
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 325S, doi. 10.1111/j.1365-2125.1983.tb02307.x
- Tanaka, M;
- Isozaki, H;
- Mizuki, Y;
- Inanaga, K
- Article
29
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 407S, doi. 10.1111/j.1365-2125.1983.tb02318.x
- Goetzke, E;
- Findeisen, P;
- Welbers, IB
- Article
30
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 231S, doi. 10.1111/j.1365-2125.1983.tb02295.x
- Article
31
- British Journal of Clinical Pharmacology, 1983, v. 16, n. S2, p. 267S, doi. 10.1111/j.1365-2125.1983.tb02299.x
- Hewett, C;
- Kreuzer, H;
- Kollmer, H;
- Niggeschulze, A;
- Stotzer, H
- Article